Table 1.
Parameter | DMH2 | JL5 |
---|---|---|
ClearanceINT (mL/min/kg) | 250 | 129 |
Plasma protein binding | 98.60% | 98.30% |
From: Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer